Literature DB >> 11897729

Patient education for H pylori: who benefits?

Katherine Yang1, B Joseph Guglielmo.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11897729      PMCID： PMC1071674     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.

Authors:  M Lee; J A Kemp; A Canning; C Egan; G Tataronis; F A Farraye
Journal:  Arch Intern Med       Date:  1999-10-25

2.  ASHP therapeutic position statement on the identification and treatment of Helicobacter pylori-associated peptic ulcer disease in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 11, 2000.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2001-02-15       Impact factor: 2.637

Review 3.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.

Authors:  R B Haynes; K A McKibbon; R Kanani
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

4.  Factors influencing the eradication of Helicobacter pylori with triple therapy.

Authors:  D Y Graham; G M Lew; H M Malaty; D G Evans; D J Evans; P D Klein; L C Alpert; R M Genta
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.